Works about INCRETINS

Results: 698

The role of broad bean albumin 1b on GIP and GLP-1 mediated alterations to glucose metabolism in diabetic mice.

Published in:

NPJ Science of Food, 2025, v. 9, n. 1, p. 1, doi. 10.1038/s41538-025-00486-9

By:

Han, Feifei;
Jin, Lu;
Zhou, Lulu;
Liu, Qi;
Ding, MengLu;
Liu, Weilin;
Han, Jianzhong

Publication type:

Article

Survodutide: a novel peptide for treatment of obesity and metabolic diseases.

Published in:

Baylor University Medical Center Proceedings, 2025, v. 38, n. 4, p. 523, doi. 10.1080/08998280.2025.2498840

By:

Vinton, Tonia Yee

Publication type:

Article

Correção da Resistência à Insulina com o Uso do Mio-inositol na Síndrome do Ovário Policístico.

Published in:

Saúde Coletiva, 2025, v. 15, n. 95, p. 15552, doi. 10.36489/saudecoletiva.2025v15i95p15552-15565

By:

Barros Marques, Anne Gabriele;
Consalter Richter, Anna Clara;
Silva Pelegrina, Ana Júlia;
de Araújo Bosco Pacheco, Isadora;
Henrique Pinto, Luciano;
Delwing-de Lima, Daniela;
Schwarz Junior, Gastão

Publication type:

Article

High-resolution lifestyle profiling and metabolic subphenotypes of type 2 diabetes.

Published in:

NPJ Digital Medicine, 2025, v. 8, n. 1, p. 1, doi. 10.1038/s41746-025-01728-6

By:

Park, Heyjun;
Metwally, Ahmed A.;
Delfarah, Alireza;
Wu, Yue;
Perelman, Dalia;
Mayer, Caleb;
McGinity, Curtis;
Rodgar, Majid;
Celli, Alessandra;
McLaughlin, Tracey;
Mignot, Emmanuel;
Snyder, Michael

Publication type:

Article

Hormone imbalances detected in study participants with pre-diabetes in a Durban-based clinical setting, South Africa.

Published in:

International Journal of Diabetes in Developing Countries, 2025, v. 45, n. 2, p. 416, doi. 10.1007/s13410-024-01363-z

By:

Sosibo, Aubrey M.;
Mzimela, Nomusa C.;
Ngubane, Phikelelani S.;
Khathi, Andile

Publication type:

Article

Revisiting the markers interleukin-6 and glucagon-like peptide-1 for targeting low-grade inflammation in type 2 diabetes: a meta-analysis and our lab experience.

Published in:

Acta Diabetologica, 2025, v. 62, n. 6, p. 811, doi. 10.1007/s00592-024-02398-8

By:

Bara, Jyoti Kiran;
Gandhi, Puneet;
Verma, Pramod

Publication type:

Article

Incretin-based therapies: advancements, challenges, and future directions in type 2 diabetes management.

Published in:

Journal of Basic & Clinical Physiology & Pharmacology, 2025, v. 36, n. 2/3, p. 95, doi. 10.1515/jbcpp-2025-0031

By:

Alluri, Amruth A.;
Guntupalli, Yashaswi;
Suvarna, Shruti Suresh;
Prystupa, Yuliya;
Khetan, Shrishti Prakash;
Vejandla, Bharath;
Babu Swathi, Naraginti Lenin

Publication type:

Article

Effect of nipa palm (Nypa fruticans Wurmb.) vinegar on the incretin hormones and intestinal glucose transporters in type 2 diabetes mellitus rat model.

Published in:

BMC Complementary Medicine & Therapies, 2025, v. 25, n. 1, p. 1, doi. 10.1186/s12906-025-04933-8

By:

Razali, Nur Izzati;
Widyawati, Tri;
Anggraini, Dwi Rita;
Lim, Vuanghao;
Yusoff, Nor Adlin

Publication type:

Article

Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review.

Published in:

Osteoporosis International, 2015, v. 26, n. 8, p. 2073, doi. 10.1007/s00198-015-3123-0

By:

Palermo, A.;
D'Onofrio, L.;
Eastell, R.;
Schwartz, A.;
Pozzilli, P.;
Napoli, N.

Publication type:

Article

Double incretin receptor knock-out (DIRKO) mice present with alterations of trabecular and cortical micromorphology and bone strength.

Published in:

Osteoporosis International, 2015, v. 26, n. 1, p. 209, doi. 10.1007/s00198-014-2845-8

By:

Mieczkowska, A.;
Mansur, S.;
Bouvard, B.;
Flatt, P.;
Thorens, B.;
Irwin, N.;
Chappard, D.;
Mabilleau, G.

Publication type:

Article

Molecular Pharmacology of the Incretin Receptors.

Published in:

2016

By:

Al-Sabah, Suleiman

Publication type:

journal article

New Online Tracker May Help Patients Find GLP-1RA Medication More Easily.

Published in:

Patient Care (Online), 2024, p. 1

By:

Jennings, Sydney

Publication type:

Article

The Incretin Effect in Female Mice With Double Deletion of GLP-1 and GIP Receptors.

Published in:

Journal of the Endocrine Society, 2020, v. 4, n. 2, p. N.PAG, doi. 10.1210/jendso/bvz036

By:

Ahrén, Bo;
Yamada, Yuichiro;
Seino, Yutaka

Publication type:

Article

At the Centennial of Michaelis and Menten, Competing Michaelis-Menten Steps Explain Effect of GLP-1 on Blood-Brain Transfer and Metabolism of Glucose.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2014, v. 115, n. 2, p. 162, doi. 10.1111/bcpt.12240

By:

Gejl, Michael;
Rungby, Jørgen;
Brock, Birgitte;
Gjedde, Albert

Publication type:

Article

Pharmacokinetic-Pharmacodynamic Modelling of Biomarker Response to Sitagliptin in Healthy Volunteers.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2013, v. 113, n. 2, p. 113, doi. 10.1111/bcpt.12068

By:

Kim, Bo‐Hyung;
Kim, Sung Eun;
Kang, Dongwoo;
Lim, Kyoung Soo;
Kim, Jung‐Ryul;
Jang, In‐Jin;
Shin, Sang‐Goo;
Yoon, Seo Hyun;
Cho, Joo‐Youn;
Yu, Kyung‐Sang

Publication type:

Article

Pharmaceutical Interventions for Diabetes Prevention in Patients at Risk.

Published in:

American Journal of Cardiovascular Drugs, 2018, v. 18, n. 1, p. 13, doi. 10.1007/s40256-017-0239-y

By:

Chatterjee, Sudesna;
Davies, Melanie;
Khunti, Kamlesh

Publication type:

Article

Lixisenatide: A New Option for Managing Type 2 Diabetes.

Published in:

Journal of Pharmacy Technology, 2017, v. 33, n. 5, p. 195, doi. 10.1177/8755122517711958

By:

Newsome, Jonathan S.

Publication type:

Article

Weekly Exenatide Therapy: A Real-World Comparison of Incretin Therapies.

Published in:

Journal of Pharmacy Technology, 2014, v. 30, n. 4, p. 118, doi. 10.1177/8755122513518189

By:

Micale, Sara J.;
Khatounabadi, Shahabodin;
Kane, Michael P.;
Busch, Robert S.;
Bakst, Gary;
Abelseth, Jill M.;
Hamilton, Robert A.

Publication type:

Article

Expression of GLP-1 receptor and CD26 in human thyroid C-cells: The association of thyroid C-cell tumorigenesis with incretin-based medicine.

Published in:

Oncology Letters, 2017, v. 13, n. 4, p. 2684, doi. 10.3892/ol.2017.5752

By:

YUEJIA SONG;
MIN ZHOU;
YANG CAO;
JIPING QI;
JINGSHU GENG;
XIAOMIN LIU

Publication type:

Article

Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis.

Published in:

2016

By:

Azoulay, Laurent;
Filion, Kristian B.;
Platt, Robert W.;
Dahl, Matthew;
Dormuth, Colin R.;
Clemens, Kristin K.;
Durand, Madeleine;
Nianping Hu;
Juurlink, David N.;
Paterson, J. Michael;
Targownik, Laura E.;
Turin, Tanvir C.;
Ernst, Pierre;
Hu, Nianping;
and the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators;
Suissa, Samy;
Hemmelgarn, Brenda R;
Teare, Gary F;
Caetano, Patricia;
Chateau, Dan

Publication type:

journal article

The impact of diabetes and obesity on fertility and the potential role of gut hormones as treatment.

Published in:

Diabetic Medicine, 2023, v. 40, n. 12, p. 1, doi. 10.1111/dme.15230

By:

Sridhar, Ananyaa;
Khan, Dawood;
Moffett, R. Charlotte

Publication type:

Article

INnoVative trial design for testing the Efficacy, Safety and Tolerability of 6‐month treatment with incretin‐based therapy to prevent type 1 DIAbetes in autoantibody positive participants: A protocol for three parallel double‐blind, randomised controlled trials (INVESTDIA)

Published in:

Diabetic Medicine, 2022, v. 39, n. 10, p. 1, doi. 10.1111/dme.14913

By:

Kero, Jukka;
Koskenniemi, Jaakko J.;
Karsikas, Sara;
Pokka, Tytti;
Lou, Olivia;
Toppari, Jorma;
Veijola, Riitta

Publication type:

Article

Basic and clinical science posters: Actions, metabolism and therapy.

Published in:: Diabetic Medicine, 2021, v. 38, p. 1, doi. 10.1111/dme.14556
Publication type:: Article

Incretin hormones, insulin, glucagon and advanced glycation end products in relation to cognitive function in older people with and without diabetes, a population‐based study.

Published in:

Diabetic Medicine, 2020, v. 37, n. 7, p. 1157, doi. 10.1111/dme.14267

By:

Dybjer, E.;
Engström, G.;
Helmer, C.;
Nägga, K.;
Rorsman, P.;
Nilsson, P. M.

Publication type:

Article

Incretin‐based drugs and risk of lung cancer among individuals with type 2 diabetes.

Published in:

Diabetic Medicine, 2020, v. 37, n. 5, p. 868, doi. 10.1111/dme.14287

By:

Rouette, J.;
Yin, H.;
Yu, O. H. Y.;
Bouganim, N.;
Platt, R. W.;
Azoulay, L.

Publication type:

Article

More recent, better designed studies have weakened links between antidiabetes medications and cancer risk.

Published in:

Diabetic Medicine, 2020, v. 37, n. 2, p. 194, doi. 10.1111/dme.14179

By:

Dankner, R.;
Roth, J.

Publication type:

Article

Loss of incretin effect contributes to postprandial hyperglycaemia in cystic fibrosis‐related diabetes.

Published in:

Diabetic Medicine, 2019, v. 36, n. 11, p. 1367, doi. 10.1111/dme.14121

By:

Frost, F.;
Jones, G. H.;
Dyce, P.;
Jackson, V.;
Nazareth, D.;
Walshaw, M. J.

Publication type:

Article

Treatment with incretins does not increase the risk of pancreatic diseases compared to older anti‐hyperglycaemic drugs, when added to metformin: real world evidence in people with Type 2 diabetes.

Published in:

Diabetic Medicine, 2019, v. 36, n. 4, p. 491, doi. 10.1111/dme.13835

By:

Montvida, O.;
Green, J. B.;
Atherton, J.;
Paul, S. K.

Publication type:

Article

Clinical care and other categories posters: Incretin therapies.

Published in:: 2019
Publication type:: Abstract

Clinical care and other categories posters: Incretin therapies.

Published in:: 2018
Publication type:: Abstract

Reducing the burden of diabetes complications.

Published in:

Diabetic Medicine, 2018, v. 35, n. 1, p. 7, doi. 10.1111/dme.13549

By:

Holt, R. I. G.

Publication type:

Article

RD Lawrence Lecture 2017 Incretins: the intelligent hormones in diabetes.

Published in:

Diabetic Medicine, 2018, v. 35, n. 1, p. 33, doi. 10.1111/dme.13522

By:

Gault, V. A.

Publication type:

Article

Clinical care and other categories posters: incretin therapies.

Published in:: Diabetic Medicine, 2017, v. 34, p. 144, doi. 10.1111/dme.29_13304
Publication type:: Article

Clinical care and other categories posters: hypoglycaemia.

Published in:: Diabetic Medicine, 2017, v. 34, p. 141, doi. 10.1111/dme.28_13304
Publication type:: Article

Sitagliptin plus pantoprazole can restore but not maintain insulin independence after clinical islet transplantation: results of a pilot study.

Published in:

Diabetic Medicine, 2017, v. 34, n. 2, p. 204, doi. 10.1111/dme.13131

By:

Senior, P. A.;
Koh, A.;
Yau, J.;
Imes, S.;
Dinyari, P.;
Malcolm, A. J.;
Light, P.;
Shapiro, A. M. J.

Publication type:

Article

Role of incretin-based therapies and sodium-glucose co-transporter-2 inhibitors as adjuncts to insulin therapy in Type 2 diabetes, with special reference to IDegLira.

Published in:

Diabetic Medicine, 2016, v. 33, n. 7, p. 864, doi. 10.1111/dme.13021

By:

Wilding, J. P. H.;
Bain, S. C.

Publication type:

Article

Clinical care and other categories posters: incretin therapies.

Published in:: Diabetic Medicine, 2016, v. 33, p. 145, doi. 10.1111/dme.36_13048
Publication type:: Article

Basic and clinical science posters: vascular and endothelial function.

Published in:: Diabetic Medicine, 2016, v. 33, p. 86, doi. 10.1111/dme.22_13048
Publication type:: Article

Effects of a Glucagon-like Peptide-1 Mimetic (Exenatide) in Healthy Cats.

Published in:

International Journal of Applied Research in Veterinary Medicine, 2012, v. 10, n. 2, p. 147

By:

Seyfert, Teresa M.;
Brunker, Jill D.;
Maxwell, Lara K.;
Payton, Mark E.;
McFarlane, Dianne

Publication type:

Article

Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.

Published in:

Drugs, 2017, v. 77, n. 1, p. 47, doi. 10.1007/s40265-016-0674-0

By:

Monte, Suzanne

Publication type:

Article

Exenatide Twice Daily: A Review of Its Use in the Management of Patients with Type 2 Diabetes Mellitus.

Published in:

2014

By:

McCormack, Paul

Publication type:

Journal Article

Contributions of Brain Insulin Resistance and Deficiency in Amyloid-Related Neurodegeneration in Alzheimer's Disease.

Published in:

2012

By:

de la Monte, Suzanne M.

Publication type:

Journal Article

Glucagon-like Peptide-1 Analogues for Type 2 Diabetes Mellitus: Current and Emerging Agents.

Published in:

2011

By:

Gallwitz, Baptist

Publication type:

Journal Article

Species-Specific Actions of Incretin: From the Evolutionary Perspective.

Published in:

Japanese Clinical Medicine, 2010, n. 1, p. 5, doi. 10.4137/JCM.S5915

By:

Kawasaki, Yukiko;
Hamamoto, Yoshiyuki;
Koshiyama, Hiroyuki

Publication type:

Article

12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with Type-2 diabetes mellitus.

Published in:

Clinical Pharmacology, 2018, v. 10, p. 141, doi. 10.2147/CPAA.S164785

By:

Perna, Simone;
Mainardi, Manuela;
Astrone, Paolo;
Gozzer, Carlotta;
Biava, Anna;
Bacchio, Ruben;
Spadaccini, Daniele;
Solerte, Sebastiano Bruno;
Rondanelli, Mariangela

Publication type:

Article

Neurological Manifestation of Incretin-Based Therapies in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.

Published in:

Aging & Disease, 2019, v. 10, n. 6, p. 1311, doi. 10.14336/AD.2019.0303

By:

Le Gao;
Shuqing Yu;
Cipriani, Andrea;
Shanshan Wu;
Yi Huang;
Zilu Zhang;
Jun Yang;
Yixin Sun;
Zhirong Yang;
Sanbao Chai;
Yuan Zhang;
Linong Ji;
Siyan Zhan;
Feng Sun

Publication type:

Article

Liraglutide in Combination with Metformin or Sulfonylurea for the Treatment of Type 2 Diabetes in Adult Patients.

Published in:

Clinical Medicine Insights: Therapeutics, 2012, n. 4, p. 251, doi. 10.4137/CMT.S7283

By:

Udiawar, Maneesh V.;
Bain, Stephen C.

Publication type:

Article

Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis.

Published in:

Diabetology & Metabolic Syndrome, 2015, v. 7, n. 1, p. 1, doi. 10.1186/s13098-015-0043-2

By:

Yuichi Terawaki;
Takashi Nomiyama;
Hiroyuki Takahashi;
Yoko Tsutsumi;
Kunitaka Murase;
Ryoko Nagaishi;
Makito Tanabe;
Tadachika Kudo;
Kunihisa Kobayashi;
Tetsuhiko Yasuno;
Hitoshi Nakashima;
Toshihiko Yanase

Publication type:

Article

The efficacy of incretin therapy in patients with type 2 diabetes undergoing hemodialysis.

Published in:

Diabetology & Metabolic Syndrome, 2013, v. 5, n. 1, p. 1, doi. 10.1186/1758-5996-5-10

By:

Terawaki, Yuichi;
Nomiyama, Takashi;
Akehi, Yuko;
Takenoshita, Hiromasa;
Nagaishi, Ryoko;
Tsutsumi, Yoko;
Murase, Kunitaka;
Nagasako, Hisahiro;
Hamanoue, Nobuya;
Sugimoto, Kaoru;
Takada, Ayako;
Ito, Kenji;
Abe, Yasuhiro;
Sasatomi, Yoshie;
Ogahara, Satoru;
Nakashima, Hitoshi;
Saito, Takao;
Yanase, Toshihiko

Publication type:

Article

Differentiating among incretin-based therapies in the management of patients with type 2 diabetes mellitus.

Published in:

Diabetology & Metabolic Syndrome, 2012, v. 4, n. 1, p. 1, doi. 10.1186/1758-5996-4-8

By:

Cobble, Michael

Publication type:

Article